Virtual Clinical Trials Market Size and Growth Opportunities and Forecast till 2026 - 2035
Virtual Clinical Trials Market Size, Share & Trends Report, 2026–2035
LAST UPDATED: OCTOBER 2026
The global Virtual Clinical Trials Market size was valued at USD 13,290.3 million in 2025 and is projected to reach USD 23,355.6 million by 2035, growing at a CAGR of 5.8% from 2026 to 2035. Growth is driven by the shift to decentralized and hybrid trial designs, remote patient recruitment and consent, wearables and home health visits, regulatory guidance supporting decentralized elements, the need to improve patient diversity and retention, and AI tools that speed up site selection, monitoring and data review.
Virtual clinical trials, also called decentralized clinical trials (DCTs), use digital technologies and remote processes so that some or all trial activities happen outside traditional research sites. These include online recruitment and electronic informed consent (eConsent), telemedicine visits, electronic patient-reported outcomes (ePRO), wearable sensors and remote monitoring, home nursing visits, direct-to-patient drug shipment and cloud-based data platforms. They are used in interventional, expanded access and observational studies across oncology, cardiovascular and other therapeutic areas.
Virtual Clinical Trials Market Key Takeaways
Infographic: Virtual Clinical Trials Market Size and Growth Opportunities and Forecast till 2026 - 2035 | Ameco Research
Virtual Clinical Trials Market Report Scope
| Report Attribute | Details |
| Virtual Clinical Trials Market Size in 2025 | USD 13,290.3 Million |
| Virtual Clinical Trials Market Forecast by 2035 | USD 23,355.6 Million |
| Virtual Clinical Trials Market CAGR (2026–2035) | 5.8% |
| Analysis Period | 2023–2035 |
| Base Year | 2025 |
| Forecast Period | 2026–2035 |
| Segments Covered | by Study Design, by Indication, and By Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | IQVIA, ICON plc (incl. PRA Health Sciences), Parexel International, Fortrea (formerly Covance clinical development), Medidata Solutions (Dassault Systèmes), Oracle Corporation, Medable, Inc., Signant Health (formerly CRF Health), Clinical Ink, Inc., and LEO Innovation Lab |
| Report Coverage | Market Trends, Drivers, Restraints, Opportunities, Competitive Analysis, Player Profiling, Regulation Analysis |
Virtual Clinical Trials Market Size Forecast, 2023–2035
Figures for 2025–2035 extend the earlier 2021 baseline of USD 10,607 million at the report's 5.8% CAGR.
| Year | Market Size (USD Million) |
| 2023 (historical) | 11,873.1 |
| 2024 (historical) | 12,561.7 |
| 2025 (base year) | 13,290.3 |
| 2026 (forecast) | 14,061.1 |
| 2027 (forecast) | 14,876.7 |
| 2028 (forecast) | 15,739.5 |
| 2029 (forecast) | 16,652.4 |
| 2030 (forecast) | 17,618.3 |
| 2031 (forecast) | 18,640.1 |
| 2032 (forecast) | 19,721.2 |
| 2033 (forecast) | 20,865.1 |
| 2034 (forecast) | 22,075.2 |
| 2035 (forecast) | 23,355.6 |
Latest Virtual Clinical Trials Market Trends (2026)
Hybrid trial designs
Most sponsors now combine site visits with remote elements, such as eConsent, telehealth and home visits, rather than running fully virtual studies.
Regulatory guidance
Regulators in the U.S. and Europe have issued guidance on decentralized elements and digital health technologies, giving sponsors clearer rules for remote data collection.
Wearables and digital endpoints
Wearable sensors and connected devices capture continuous data on activity, heart rate and other measures, supporting new digital endpoints.
AI in trial operations
AI helps identify sites and eligible patients, monitor data quality and flag risks, reducing delays and costs.
Diversity and access
Remote participation helps reach patients who live far from research sites, supporting goals to improve diversity in clinical trials.
Platform consolidation
Clinical research organizations and technology vendors are integrating eConsent, ePRO, telehealth and data platforms into unified decentralized trial solutions.
Virtual Clinical Trials Market Dynamics
Growth drivers
- Need to speed up patient recruitment and reduce trial costs
- Patient demand for convenient participation
- Growth of telehealth, wearables and digital health
- Regulatory support for decentralized elements
- Goals to improve trial diversity and retention
Restraints and challenges
- Data privacy, security and integrity concerns
- Variable regulations across countries
- Technology access and digital literacy gaps among patients
- Complexity of integrating multiple platforms
Opportunities
Key opportunities include hybrid trial services, digital endpoints, AI for recruitment and monitoring, rare disease and oncology trials, and expansion of decentralized trials in Asia Pacific and Latin America.
Virtual Clinical Trials Market Segment Analysis
By study design
The market is segmented into interventional, expanded access and observational studies. Interventional trials are expected to dominate, while observational and real-world evidence studies widely use remote data collection.
By indication
Indications include oncology, cardiovascular and others. Oncology holds a large share because of the high number of cancer trials, while cardiovascular trials benefit from remote monitoring of vital signs.
Virtual Clinical Trials Market Regional Analysis
North America has historically held the largest share, supported by large pharma R&D spending, many technology vendors and regulatory guidance on decentralized trials.
Europe is a major market, with growing use of remote elements under evolving EU rules. Asia Pacific is expected to grow fast, driven by large patient populations and rising trial activity in China, India and Australia.
Latin America and the Middle East & Africa are growing trial locations, using remote tools to reach wider patient populations.
Virtual Clinical Trials Market Segmentation
Virtual Clinical Trials Market Leading Companies
The virtual clinical trials market includes contract research organizations, clinical trial technology vendors, digital health platforms and home health service providers. Companies compete on platform integration, regulatory compliance, patient experience, global reach and data quality. Key players profiled in this report include IQVIA, ICON plc (incl. PRA Health Sciences), Parexel International, Fortrea (formerly Covance clinical development), Medidata Solutions (Dassault Systèmes), Oracle Corporation, Medable, Inc., Signant Health (formerly CRF Health), Clinical Ink, Inc., and LEO Innovation Lab.
IQVIAICON plc (incl. PRA Health Sciences)Parexel InternationalFortrea (formerly Covance clinical development)Medidata Solutions (Dassault Systèmes)Oracle CorporationMedable, Inc.Signant Health (formerly CRF Health)Clinical Ink, Inc.LEO Innovation Lab
Key Questions Answered in This Report
- What is the size of the virtual clinical trials market in 2025, and how large will it be by 2030 and 2035?
- What are the main growth drivers, restraints and opportunities through 2035?
- Which by study design and by indication segments will grow the fastest?
- Which regions and countries offer the largest and fastest-growing opportunities?
- How are hybrid designs, regulatory guidance and AI shaping virtual clinical trials in 2026?
- Who are the leading companies, and what strategies are they using to compete?
Research Methodology
Our estimates draw on interviews with contract research organizations, trial technology vendors, sponsors, regulators and published literature, supported by secondary data from annual reports, investor materials, trade and customs data, standards bodies and industry journals. Bottom-up estimates of company revenues and top-down estimates of application demand are reconciled through data triangulation, and the model is updated with 2026 developments to forecast the market through 2035.
Related Reports
- Veterinary Telehealth Market Report
- Next Generation Sequencing Market Report
- Telehealth Market Report
- Precision Medicine Market Report
- Artificial Intelligence in Drug Discovery Market Report
Virtual Clinical Trials Market: Frequently Asked Questions
How big is the virtual clinical trials market?
The global virtual clinical trials market was valued at USD 13,290.3 million in 2025 and is expected to reach USD 23,355.6 million by 2035.
What is the growth rate of the virtual clinical trials market?
The virtual clinical trials market is projected to grow at a CAGR of 5.8% from 2026 to 2035.
What will the virtual clinical trials market be worth in 2030?
The virtual clinical trials market is projected to reach about USD 17,618.3 million in 2030, growing at a CAGR of 5.8%.
What is driving growth in the virtual clinical trials market?
Key drivers are faster recruitment and lower costs, patient convenience, telehealth and wearables, regulatory support and diversity goals.
What is virtual clinical trials?
Virtual clinical trials, or decentralized clinical trials, use digital tools and remote processes so participants can take part in studies from home instead of visiting research sites.
Which region leads the virtual clinical trials market?
North America has historically held the largest share, while Asia Pacific is expected to grow fast.
Which segment holds the largest share of the virtual clinical trials market?
Interventional trials are expected to dominate by study design, and oncology holds a large share by indication.
What are the latest trends in the virtual clinical trials market?
The main 2026 trends are hybrid trial designs, regulatory guidance, wearables and digital endpoints, aI in trial operations, diversity and access and platform consolidation.
What are the main challenges in the virtual clinical trials market?
The main challenges are data privacy and integrity, variable regulations, patient technology access and platform integration.
What is a hybrid clinical trial?
A hybrid clinical trial combines some traditional site visits with remote activities such as eConsent, telehealth visits, home nursing and wearable data collection.
Who are the key players in the virtual clinical trials market?
Leading companies include IQVIA, ICON plc (incl. PRA Health Sciences), Parexel International, Fortrea (formerly Covance clinical development), Medidata Solutions (Dassault Systèmes), Oracle Corporation, Medable, Inc., Signant Health (formerly CRF Health), Clinical Ink, Inc., and LEO Innovation Lab.
Related Pharma & Healthcare Market Reports
- Radiation Oncology Market Size and Growth Opportunities and Forecast till 2026 - 2035
- Virtual Reality Headset Market Size and Growth Opportunities and Forecast till 2026 - 2035
- Pelvic Floor Electric Stimulator Market Size and Growth Opportunities and Forecast till 2026 - 2035
- Mesenchymal Stem Cells Market Size and Growth Opportunities and Forecast till 2026 - 2035
- Anti-Allergic Drugs Market Size and Growth Opportunities and Forecast till 2026 - 2035